Akari Therapeutics (AKTX) EPS (Basic) (QoQ) (2014 - 2026)
Akari Therapeutics (AKTX) EPS (Basic) (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -3,009,773.78% |
| Sep 30, 2025 | -108.50% |
| Jun 30, 2025 | 25.82% |
| Mar 31, 2025 | 57.02% |
| Dec 31, 2024 | -3.15% |
| Sep 30, 2024 | 67.04% |
| Jun 30, 2024 | -4.36% |
| Mar 31, 2024 | 14.30% |
| Dec 31, 2023 | -110.94% |
| Sep 30, 2023 | 52.83% |
| Jun 30, 2023 | 14.53% |
| Dec 31, 2020 | -13,966.70% |
| Sep 30, 2020 | 96.68% |
| Jun 30, 2020 | -9.42% |
| Mar 31, 2020 | 54.19% |
| Dec 31, 2019 | -170.38% |
| Sep 30, 2019 | 58.22% |
| Jun 30, 2019 | -45,246.77% |
| Mar 31, 2016 | -115.00% |